Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,448 | 9,736 | 9,005 | 6,871 | 7,286 |
| Marketable Securities | 8,060 | 40 | N/A | 3,007 | 12,046 |
| Receivables | 2,000 | 213 | 95 | 663 | 1,060 |
| TOTAL | $16,421 | $10,277 | $9,114 | $10,541 | $20,392 |
| Non-Current Assets | |||||
| PPE Net | 648 | 685 | 388 | 71 | 91 |
| Investments And Advances | 0 | 0 | 0 | 18 | 33 |
| Other Non-Current Assets | 491 | 72 | 38 | 0 | 0 |
| TOTAL | $1,139 | $757 | $426 | $89 | $124 |
| Total Assets | $17,560 | $11,034 | $9,540 | $10,630 | $20,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 316 | 186 | 62 | 1,931 | 2,514 |
| Accrued Expenses | 2,264 | 944 | 634 | N/A | N/A |
| Other current liabilities | 3,400 | N/A | N/A | N/A | N/A |
| TOTAL | $5,980 | $1,130 | $696 | $1,931 | $2,514 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 298 | 198 | 351 | 0 | 70 |
| TOTAL | $298 | $198 | $351 | $N/A | $70 |
| Total Liabilities | $6,278 | $1,328 | $1,047 | $1,931 | $2,584 |
| Shareholders' Equity | |||||
| Common Shares | 1,151 | 396 | 396 | 45 | 39 |
| Retained earnings | -25,673 | -16,289 | -12,047 | -39,809 | -23,787 |
| Other shareholders' equity | -1,300 | -2,251 | -1,503 | 0 | 0 |
| TOTAL | $11,282 | $9,706 | $8,493 | $8,699 | $17,932 |
| Total Liabilities And Equity | $17,560 | $11,034 | $9,540 | $10,630 | $20,516 |